Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Halozyme Shares Soared

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of biopharmaceutical company Halozyme Therapeutics (NASDAQ: HALO  ) surged 28% today after entering a collaboration agreement with drug giant Pfizer (NYSE: PFE  ) to develop injectable medicines.

So what: Halozyme shares were battered in 2012 on concerns over the immune-deficiency treatment it developed with Baxter International (NYSE: BAX  ) , but today's announcement suggests that pharmaceutical giants still have faith in Halozyme's Enhanze drug-delivery platform. In fact, Halozyme will receive an initial payment of $8 million and stands to gain a whopping $507 million if Pfizer reaches certain milestones, rekindling optimism over its growth prospects going forward.

Now what: I'd expect today's news to keep lifting the shares in the short term. "We look forward to working with Pfizer to apply Enhanze to these exciting targets," said Halozyme President and CEO Gregory Frost, Ph.D. "Enhanze enables biologics to be delivered as a simple subcutaneous injection." Of course, when you consider that Halozyme remains unprofitable and that the stock largely sways on fickle FDA decisions, conservative long-term investors should look elsewhere.

Interested in more info on Halozyme? Add it to your watchlist.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2166906, ~/Articles/ArticleHandler.aspx, 10/20/2016 3:42:14 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,179.58 -23.04 -0.13%
S&P 500 2,140.75 -3.54 -0.17%
NASD 5,243.17 -3.24 -0.06%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/20/2016 3:26 PM
BAX $48.22 Up +0.39 +0.82%
Baxter CAPS Rating: ****
HALO $9.64 Up +0.33 +3.49%
Halozyme Therapeut… CAPS Rating: ***
PFE $32.62 Up +0.02 +0.06%
Pfizer CAPS Rating: ****